[HTML][HTML] The role of leptin and adiponectin in obesity-associated cognitive decline and Alzheimer's disease

L Forny-Germano, FG De Felice… - Frontiers in …, 2019 - frontiersin.org
Cross-talk between adipose tissue and central nervous system (CNS) underlies the
increased risk of obese people to develop brain diseases such as cognitive and mood …

Obesity, leptin, and Alzheimer's disease

EB Lee - Annals of the New York Academy of Sciences, 2011 - Wiley Online Library
Obesity has various deleterious effects on health largely associated with metabolic
abnormalities including abnormal glucose and lipid homeostasis that are associated with …

Obesity as a risk factor for Alzheimer's disease: the role of adipocytokines

L Letra, I Santana, R Seiça - Metabolic brain disease, 2014 - Springer
Alzheimer's disease is the leading cause of dementia and the most prevalent
neurodegenerative disease. It is an aging-related multi-factorial disorder and growing …

Obesity, adipokines and neuroinflammation

A Aguilar-Valles, W Inoue, C Rummel, GN Luheshi - Neuropharmacology, 2015 - Elsevier
Global levels of obesity are reaching epidemic proportions, leading to a dramatic increase in
incidence of secondary diseases and the significant economic burden associated with their …

Obesity and dementia: adipokines interact with the brain

IAC Arnoldussen, AJ Kiliaan, DR Gustafson - European …, 2014 - Elsevier
Obesity is a pandemic and a serious global health concern. Obesity is a risk factor for
multiple conditions and contributes to multi-morbidities, resulting in increased health costs …

The novel perspectives of adipokines on brain health

TH Lee, KK Cheng, RL Hoo, PM Siu, S Yau - International journal of …, 2019 - mdpi.com
First seen as a fat-storage tissue, the adipose tissue is considered as a critical player in the
endocrine system. Precisely, adipose tissue can produce an array of bioactive factors …

Leptin dysfunction and Alzheimer's disease: evidence from cellular, animal, and human studies

MJ McGuire, M Ishii - Cellular and molecular neurobiology, 2016 - Springer
There is accumulating evidence from epidemiological studies that changes in body weight
are associated with Alzheimer's disease (AD) from mid-life obesity increasing the risk of …

Chronic oral administration of adipoRon reverses cognitive impairments and ameliorates neuropathology in an Alzheimer's disease mouse model

RCL Ng, M Jian, OKF Ma, M Bunting, JSC Kwan… - Molecular …, 2021 - nature.com
Circulating adiponectin (APN) levels decrease with age and obesity. On the other hand, a
reduction in APN levels is associated with neurodegeneration and neuroinflammation. We …

Adiponectin in plasma and cerebrospinal fluid in MCI and Alzheimer's disease

K Une, YA Takei, N Tomita, T Asamura… - European Journal of …, 2011 - Wiley Online Library
Background and purpose: Life style‐related disorders such as hypertension, diabetes,
dyslipidemia, and obesity are reported to be a great risk of dementia. Adipocytokines …

Adiposity and cognitive decline: underlying mechanisms

DR Gustafson - Journal of Alzheimer's Disease, 2012 - content.iospress.com
Level of adiposity is linked to manifest dementia and Alzheimer's disease in epidemiological
studies. Overweight and obesity in mid-and late-life may increase risk for dementia, whereas …